The use of GnRHa alone as a trigger has been recommended for patients at risk of OHSS undergoing ovarian stimulation and prescribed GnRH antagonists to block the early LH surge (ORPI/BAND E). This evidence concerns the gene GNRH1 and ovarian hyperstimulation syndrome.